|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.29 CHF | +1.75% |
|
+0.32% | -5.30% |
| Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Idorsia Pharmaceuticals Ltd agreed to acquire 17.72% stake in Santhera Pharmaceuticals Holding AG (SWX:SANN) on January 10, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.30% | 116M | |
| +8.05% | 72.03B | |
| -11.95% | 5.14B | |
| +51.87% | 4.6B | |
| +3.92% | 3.96B | |
| -14.26% | 2.5B | |
| +20.42% | 2.43B | |
| -23.94% | 2.32B | |
| +20.02% | 2.18B | |
| +3.35% | 1.72B |
SANTHERA PHARMACEUTICALS HOLDING AG 